Health Condition 1: C34- Malignant neoplasm of bronchus andlung
Conditions
Interventions
None listed
Sponsors
Tata Memorial Centre
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with metastatic lung cancer being treated currently with cytotoxic palliative chemotherapy +/- targeted therapy. 2. Patients currently on first line palliative chemotherapy who have completed at least 2 cycles 3. Patients who are not more than 6 months into their course of palliative chemotherapy and intend to continue chemotherapy
Exclusion criteria
Exclusion criteria: 1. Patients who have completed the planned chemotherapy. 2. Patients with brain metastases or other conditions which affects cognition and the ability to complete the survey/interview.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To estimate the number of months of improvement in survival that patients consider enough benefit for palliative chemotherapy over best supportive carein patients with metastatic lung cancers 2. To evaluate factors influencing the patient preference of treatment 3.Subset analysis will be performed to see variation in survival thresholds for patients on cytotoxic chemotherapy (+/targeted therapy) and targeted therapy alone.Timepoint: At recruitment baseline evaluation and no furthur follow up | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicableTimepoint: Not applicable | — |
Countries
India
Contacts
Public ContactDr C S Pramesh
Tata Memorial Centre
Outcome results
None listed